You are here: vision-research.eu » Vision Research » Vision in the European Focus » Retinoblastoma – An International Update

Retinoblastoma – An International Update

The 3rd international meeting will take place from September 7th-8th, 2018 at the Bambino Gesu Children’s Hospital in Rome, Italy

This meeting is to enhance the clinical and preclinical knowledge on Retinoblastoma through advanced discussion amongst the experts in the field. In particular, we propose an update on molecular biology, diagnosis, conservative and non-conservative Retinoblastoma management, radiological guidelines, late effects and quality of life.

The European Retinoblastoma Group (EURbG) scientifically supports this initiative (for details please see below); the Bambino Gesu Paediatric Hospital is actively involved as member of the EURbG.

Main objectives are:

  • Improve the care of patients with retinoblastoma,
  • Improve access to specialist retinoblastoma care across Europe,
  • Improve knowledge and understanding of retinoblastoma,
  • To provide access to reliable, consistent information.

Course directors will be  Profs. Raffaele Cozza and Antonio Romanzo.

About the Baby Jesus Paediatric Hospital - Ospedale Pediatrico Bambino Gesù

Ospedale Pediatrico Bambino Gesù (Baby Jesus Paediatric Hospital) is a children's hospital located in Rome, Italy. It accomplishes its institutional Christian testimony by providing public services in the healthcare field.

The hospital, which was founded in 1869, is now part of the network of the National Healthcare System in the city of Rome on extraterritorial area administered by the Holy See. Since 1980, due to its prestige and to the strengthening of its relations with the Italian National Health System, it has become a significant point of reference for paediatrics at the national level.

The trademark of the hospital in the last thirty years has been the high level of specialization in the treatment of children coming not only from Rome or Italy, but also from neighbouring European countries. In 1985 it was officially recognized as a research hospital (Istituto di Ricovero e Cura a Carattere Scientifico), thus being included among the most important national comprehensive hospitals and becoming one of the three children’s research hospitals in Italy.

More information on the website http://www.ospedalebambinogesu.it/en/chi-siamo

What Is Retinoblastoma?

Retinoblastoma is cancer of the eye. It begins in the retina, the layer of nerve cells lining the back of the eye. It happens when nerve cells in the retina change, growing in size and number. The cells eventually form a tumor. The cells usually spread in and around the eye. They can also spread to other parts of the body, including the brain and spine.

Retinoblastoma usually affects young children, though it can sometimes occur in adults. Children with retinoblastoma may have inherited a gene from their parents that causes this disease. These children tend to get retinoblastoma at an earlier age, and in both eyes.

The European Retinoblastoma Group (EURbG)

EURbG is a pan-European partnership between professionals involved in the care of retinoblastoma (RB) and families and patients affected by retinoblastoma with a common goal to share and disseminate knowledge and experience within Europe. There is a shared vision to identify the problems within RB management and develop tools to address them through the creation of a retinoblastoma network.

This network aims to crystallize into a formal partnership an extensive group of RB specialists from all major centres into a single structure with genuine European dimension.

More information: http://www.eurbg.org/portal/